Accordingly, Lamb et al [33] reported that cyclin D1 overexpression increases migration and more aggressive behavior in ER-positive breast cancer cell lines, whereas in ER-negative cell lines the opposite occurs, supporting different effects of cyclin D1 expression in ER-positive and ER-negative cells. Here, CCND1 is linked to breast cancer.